Tag Archives: EPO

Neutrokine-α litigation – On a different record from that before the EPO Appeal Board, the UK Court of Appeal finds different facts with a different result

From Paul Cole of Lucas & Cole On February 9th the Court of Appeal ([2010] EWCA Civ 33; Jacob L.J.) held that Human Genome Sciences Patent EP-B-093 cheap cialis online 9804 for Neutrokine-α did not meet the industrial applicability requirement … Continue reading

Posted in Utility/How-To-Use | Tagged , , , , | Leave a comment

Recent EPC rule changes restrict filing of Divisional Applications

Attached is an article by Malcolm Lawrence of HLBBshaw, Epping, UK 1. Background On 25th March 2009, the Administrative Council of the European Patent Organisation issued decision CA/D 2/09 which introduces stricter requirements regarding the filing of divisional applications. These … Continue reading

Posted in EP and UK Practice | Tagged , , , , , | Leave a comment

TRANSMISSION OF INFORMATION IN EUROPE – PATENTABLE SUBJECT MATTER?

By Paul Cole, Lucas & Co., UK The UK counterpart of In re Ngai is Bayer’s (Meyer’s) Application [1984] R.P.C. 11. In that case a claim to a package containing a known drug together with instructions for a new use … Continue reading

Posted in Non-U.S. Practice | Tagged , , , , , , , | Leave a comment